Treatment for Hormone Sensitive Prostate Cancer
AUAUniversity9 Elo 2023

Treatment for Hormone Sensitive Prostate Cancer

Treatment for Hormone Sensitive Prostate Cancer CME Available: https://auau.auanet.org/node/38703 Treatment for Hormone Sensitive Prostate Cancer (2023), is an exciting new educational offering to update urologists on the latest advancements in the management of hormone sensitive prostate cancer (HSPC), including treatment intensification. This educational initiative is comprised of multiple formats, including a live virtual course, on-demand webcast, and a podcast. This live virtual course, which is the cornerstone of the initiative features a multidisciplinary panel, engaging in a lively discussion. At the conclusion of this activity, participants will be able to: 1. Apply the AUA Clinical Guidelines for Advanced Prostate Cancer for the treatment of HSPC. 2. Summarize the current utilization of treatment intensification in HSCP and apply appropriate treatment intensification in men with HSPC. 3. Describe the current indications, potential benefits and adverse events that may occur with use of doublet and triplet regimens as compared to SOC in HSPC. 4. Identify opportunities for shared care and team-based approaches to offer state-of-the-art evidenced care for HSPC. 5. Facilitate discussions with patients and caregivers to engage them in the HSPC treatment plan. ACKNOWLEDGEMENT This educational activity is supported by an independent educational grant from: Astellas Pfizer, Inc.

Jaksot(421)

AUA2018 Take Home Messages Pediatrics plus Highlights From SPU and Journal of Urology

AUA2018 Take Home Messages Pediatrics plus Highlights From SPU and Journal of Urology

Take Home Messages from AUA2018 in Pediatrics presented by Emilie Johnson, MD, MPH. In addition Plenary Next Frontier presentations in the area of pediatric urology Highlights: Society for Pediatr...

6 Joulu 201823min

Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer Highlights (2018)

Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer Highlights (2018)

This podcast was developed from content delivered during the Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer live course. Topics covered include: Practical Guide to an...

30 Marras 20181h 36min

Immuno-Oncology: A Focus on Prostate Cancer

Immuno-Oncology: A Focus on Prostate Cancer

Immuno-Oncology: A Focus on Prostate Cancer is the fourth webcast in the 4-part series. Topics will include "review of treatment options for advanced disease", "evolution of AR-directed treatment and ...

25 Marras 20181h 6min

AUA2018 Residents Forum - The Evolving Practice Of Urology

AUA2018 Residents Forum - The Evolving Practice Of Urology

AUA2018 Residents Forum - The Evolving Practice Of Urology by American Urological Association

15 Marras 201838min

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career by American Urological Association

13 Marras 201843min

Immuno-Oncology: A Focus on Kidney Cancer

Immuno-Oncology: A Focus on Kidney Cancer

Immuno-Oncology: A Focus on Kidney Cancer is the third in the 4-part series. Topics will include "Review of Treatment Options for Systemic Disease", "Cytoeduction Debate" and "Impact of Immunotherapy ...

8 Marras 201847min

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer Present and Future (2018)

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer Present and Future (2018)

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer: Present and Future is the fourth and final in a 4-part series. Topics will include "Role of Chemotherapy and Performance Sta...

1 Marras 201844min

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

29 Loka 201837min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
rss-narsisti
adhd-podi
rss-liian-kuuma-peruna
rss-niinku-asia-on
rss-valo-minussa-2
aamukahvilla
rss-vapaudu-voimaasi
rss-arkea-ja-aurinkoa-podcast-espanjasta
kesken
jari-sarasvuo-podcast
salainen-paivakirja
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-uskonto-on-tylsaa
rss-luonnollinen-synnytys-podcast
rss-koira-haudattuna
rss-hereilla
filocast-filosofian-perusteet